Long-awaited, poised for launch.2023 Beijing International Life and Health Industry ExpoAs the opening approaches, we cordially invite colleagues from relevant institutions across China to gather in Beijing and jointly write a new chapter in the development of the life and health industry.

Rooted in China and open to the world, we uphold the concept of jointly building a global community of health for all, sharing high-quality medical and health resources as well as achievements in scientific and technological innovation, with“A Community of Life and Health, Together We Move Toward the Future”as the theme, we are committed to building an international exchange platform for the global human life and health industry that connects supply with demand, shares business opportunities, and promotes collaborative development. The exhibition will last for three days,50,000 sqm Large-ScaleExhibition Space,Over 600 High-Quality Exhibitors, planned and established during the same period30 Thematic Forums, featuring over 100 event topics, technical exchange sessions, product matchmaking and negotiation activities, international cooperation project promotion conferences, investment promotion activities for the Zhongguancun Life and Health Industrial Park, and other supporting events, to create a one-stop procurement matchmaking and exchange platform.

Conference Time

Time: July 11–13, 2023

Conference Venue

Venue: China International Exhibition Center (Chaoyang Hall)

Detailed Address: No. 6, North Third Ring Road East, Chaoyang District, Beijing

Dedicated to serving healthcare and advancing the health industry, this edition of the exhibition strives to promote synergistic development between public healthcare services and the medical service sector. It has attracted participation from leading industry enterprises such as Shenzhen Mindray, Anke, BGI, Yiling Pharmaceutical, Fosun, Alltech Medical Systems, ShuRui, CanSinoBIO, Airdoc, Hybribio, Kangtai Biological Products, Sinocare, Shukun Technology, AnHan Technology, Simcere Pharmaceutical, and Joysun Biotech. The event is committed to building a new “one exhibition, multiple dimensions” paradigm that leverages the platform to facilitate industry showcases and exchanges, share emerging trends, and connect resources.

1. Focus on China, Keep a Global Perspective

2023 Beijing International Life and Health Industry ExpoLaunch a global promotional campaign, extending invitations to hundreds of thousands of domestic and international buyers, over 100 global partners, more than 200 commercial offices of Chinese embassies and consulates abroad, the World Health Organization, United Nations agencies, health departments of select countries, international medical institutions, local government bodies, the National Health Commission, Centers for Disease Control and Prevention, hospitals and healthcare facilities, and Fortune Global 500 companies.

2. Innovative Approaches, Joint Empowerment

The conference was held in a hybrid format, combining online and offline elements, attracting suppliers, buyers, and professional attendees from both domestic and international markets. The expo regularly hosts online supply-and-demand matchmaking events for multinational healthcare companies in key countries and markets, focusing on new trends in the global life and health industry and establishing an international platform for cooperation and exchange in the life and health sector.

3. Multi-dimensional Circles, Igniting the Market

This conference will bring together tens of thousands of industry peers, forming a multi-tiered ecosystem comprising diverse institutions and communities across various sectors focused on the development of the life and health industry. This structure enables every participant to quickly identify and integrate into relevant networks, fostering dialogue with peers, resonating with professional expertise, integrating within communities, and achieving symbiotic growth with the industry. The event will serve as a pivotal platform for matching supply with demand and as a key engine for industrial innovation and development, guiding trends in the life and health sector and aligning with market demands to promote integrated industrial advancement.

Conclusion

The 2023 Beijing International Life and Health Industry Expo is committed to building a cooperative exchange platform for exhibitors and medical and health institutions, bringing new opportunities and vitality to the industry, and supporting innovative development of enterprises. From July 11 to 13, 2023, we look forward to meeting you at the China International Exhibition Center in Beijing—see you there! (Specific registration methods are as follows)

Scan the WeChat QR code to access the mini-program and register for free (limited-time offer for attendees).

About VCBeat: VCBeat (a brand under Danke Technology) is an innovative industry service organization that leverages data as its foundation, research as its core, and brand media as its connector to facilitate the precise aggregation of industrial resources and help industry changemakers achieve rapid growth. Focusing on the life and health sector, VCBeat, together with its affiliated brands VB100, VCBeat Research Institute, and VCBeat Orange, provides services such as brand communication, research consulting, data monitoring, and resource/project matchmaking for enterprises, government industrial parks, investment institutions, and other entities within the industry chain. Founded in 2014, over the past eight years we have published more than 21,000 medical articles and over 500 original industry reports, covered nearly 10,000 companies, built a database of more than 170,000 companies, and successfully hosted seven editions of the Future Healthcare Top 100 Conference. It has become the preferred interactive platform for innovation, entrepreneurship, investment, and corporate development. Since its establishment, VCBeat has received investments from several well-known firms, including Legend Capital, BV Baidu Venture Capital, Honghui Capital, Changling Capital, Yifang Group, and Weilai Capital, achieving a valuation of hundreds of millions of RMB.